• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视力变异性:比较进入前瞻性试验的受试者中 Snellen 和 ETDRS 测量结果的差异。

Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials.

机构信息

Retina Consultants of Houston, Retina Consultants of America, Houston, Texas.

Vitreoretinal Service, Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio.

出版信息

Ophthalmol Retina. 2021 Mar;5(3):224-233. doi: 10.1016/j.oret.2020.04.011. Epub 2020 Apr 23.

DOI:10.1016/j.oret.2020.04.011
PMID:32595096
Abstract

PURPOSE

To compare the variability between Snellen visual acuity (VA) and Early Treatment Diabetic Retinopathy (ETDRS) best-corrected VA (BCVA) measurements.

DESIGN

Retrospective chart review.

PARTICIPANTS

Eyes from subjects entering 12 prospective retinal trials in a large, urban retina practice.

METHODS

Eyes were included if a Snellen VA measurement was performed at the visit preceding trial screening and VA was better than counting fingers. Snellen VA and ETDRS BCVA were then converted to logarithm of the minimum angle of resolution (logMAR) units, and the variability between measurements was calculated.

MAIN OUTCOME MEASURES

Outcome measures include VA variability among disease states, absolute VA, and central subfield thickness (CST).

RESULTS

A total of 773 eyes of 413 subjects were identified with a mean of 27.2 days (median, 19; 95% confidence interval [CI], 25.1-29.3) between measurements. Mean Snellen and ETDRS measurements were 0.40 (20/50) and 0.27 logMAR (20/40), respectively. Overall, mean ETDRS BCVA was 6.1 letters better than Snellen VA (median, 5.8; 95% CI, 5.3-7.0; P < 0.05); 76.6% of eyes had improved ETDRS. Restricting the number of days between measurements did not result in any meaningful differences from this directionality. Among eyes with worse VA, variation was more pronounced than among eyes with better VA; eyes 20/25 or better were a mean +1.9 letters better on ETDRS testing (P < 0.05) and eyes 20/160 or worse were a mean +12.6 letters better on ETDRS testing (P < 0.05). Subgroup analyses by disease state found statistically significantly better vision measurements with the ETDRS protocol compared with Snellen in 4 of the 5 disease states studied. Although lens status did not affect the extent of discrepancy between ETDRS and Snellen measurements, amount of retinal edema (CST) did: increased CST correlated with increased variability.

CONCLUSIONS

The ETDRS protocol BCVA measurement resulted in significantly better scores when compared with Snellen VA measurements. This difference was more pronounced among eyes with worse VA. Additionally, specific retinal disease states and anatomic variables such as extent of retinal edema (CST) may have a meaningful impact on the anticipated variability between ETDRS and Snellen VA measurement.

摘要

目的

比较 Snellen 视力(VA)和早期糖尿病视网膜病变治疗研究(ETDRS)最佳矫正视力(BCVA)测量之间的变异性。

设计

回顾性图表审查。

参与者

来自大型城市视网膜实践中参加 12 项前瞻性视网膜试验的受试者的眼睛。

方法

如果在试验筛选前的就诊时进行了 Snellen VA 测量,并且 VA 优于数手指,则将眼睛纳入研究。然后将 Snellen VA 和 ETDRS BCVA 转换为最小角分辨率的对数(logMAR)单位,并计算测量之间的变异性。

主要观察指标

观察指标包括疾病状态之间的 VA 变异性、绝对 VA 和中央视网膜厚度(CST)。

结果

共确定了 773 只眼睛的 413 名受试者,两次测量之间的平均时间为 27.2 天(中位数为 19;95%置信区间[CI],25.1-29.3)。Snellen 和 ETDRS 的平均测量值分别为 0.40(20/50)和 0.27 logMAR(20/40)。总体而言,ETDRS BCVA 平均比 Snellen VA 好 6.1 个字母(中位数,5.8;95%CI,5.3-7.0;P<0.05);76.6%的眼睛 ETDRS 改善。限制两次测量之间的天数并没有导致这种方向性的任何有意义的差异。在 VA 较差的眼睛中,变异性比 VA 较好的眼睛更明显;VA 为 20/25 或更好的眼睛在 ETDRS 测试中平均提高了 1.9 个字母(P<0.05),VA 为 20/160 或更差的眼睛在 ETDRS 测试中平均提高了 12.6 个字母(P<0.05)。按疾病状态进行的亚组分析发现,在研究的 5 种疾病状态中,有 4 种状态的 ETDRS 方案与 Snellen 相比,视力测量结果明显更好。尽管晶状体状态并不影响 ETDRS 和 Snellen 测量之间差异的程度,但视网膜水肿(CST)的程度确实有影响:CST 增加与变异性增加相关。

结论

与 Snellen VA 测量相比,ETDRS 方案 BCVA 测量结果明显更好。在 VA 较差的眼睛中,这种差异更为明显。此外,特定的视网膜疾病状态和解剖学变量,如视网膜水肿(CST)的程度,可能对 ETDRS 和 Snellen VA 测量之间的预期变异性有重要影响。

相似文献

1
Visual Acuity Variability: Comparing Discrepancies between Snellen and ETDRS Measurements among Subjects Entering Prospective Trials.视力变异性:比较进入前瞻性试验的受试者中 Snellen 和 ETDRS 测量结果的差异。
Ophthalmol Retina. 2021 Mar;5(3):224-233. doi: 10.1016/j.oret.2020.04.011. Epub 2020 Apr 23.
2
Comparison of Snellen Visual Acuity Measurements in Retinal Clinical Practice to Electronic ETDRS Protocol Visual Acuity Assessment.视网膜临床实践中的 Snellen 视力测量与电子 ETDRS 协议视力评估的比较。
Ophthalmology. 2023 May;130(5):533-541. doi: 10.1016/j.ophtha.2022.12.008. Epub 2022 Dec 12.
3
Efficacy of Ranibizumab in Eyes with Diabetic Macular Edema and Macular Nonperfusion in RIDE and RISE.雷珠单抗治疗糖尿病性黄斑水肿及黄斑无灌注的疗效:随机、对照、多中心 RIDE 和 RISE 研究
Ophthalmology. 2018 Oct;125(10):1568-1574. doi: 10.1016/j.ophtha.2018.04.002. Epub 2018 May 8.
4
Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.比较玻璃体内注射贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿。
J Ocul Pharmacol Ther. 2011 Aug;27(4):373-7. doi: 10.1089/jop.2010.0195. Epub 2011 Jun 1.
5
Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis).视力评估的前瞻性研究:临床实践中Snellen视力表与ETDRS视力表的比较(一篇美国眼科学会论文)
Trans Am Ophthalmol Soc. 2009 Dec;107:311-24.
6
Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.玻璃体内注射贝伐单抗(阿瓦斯汀)对慢性弥漫性糖尿病性黄斑水肿患者的长期影响。
Retina. 2008 Oct;28(8):1053-60. doi: 10.1097/IAE.0b013e318176de48.
7
Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes.临床试验中采用ETDRS视力表与斯内伦视力表测试时视力变化的幅度:对基于临床的结果的影响
Ophthalmol Sci. 2023 Jul 19;4(2):100372. doi: 10.1016/j.xops.2023.100372. eCollection 2024 Mar-Apr.
8
Five-Year Outcomes after Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T Extension Study).初始阿柏西普、贝伐单抗或雷珠单抗治疗糖尿病性黄斑水肿的 5 年结果(协议 T 扩展研究)。
Ophthalmology. 2020 Sep;127(9):1201-1210. doi: 10.1016/j.ophtha.2020.03.021. Epub 2020 Mar 29.
9
Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.比较贝伐单抗和雷珠单抗治疗糖尿病性黄斑水肿患者的疗效(BRDME):BRDME研究,一项随机试验。
Ophthalmol Retina. 2020 Aug;4(8):777-788. doi: 10.1016/j.oret.2020.02.008. Epub 2020 Feb 27.
10
Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.雷珠单抗或阿柏西普治疗糖尿病性黄斑水肿:抗视网膜病变!注册研究的 1 年结局比较。
Ophthalmology. 2020 May;127(5):608-615. doi: 10.1016/j.ophtha.2019.11.018. Epub 2019 Nov 26.

引用本文的文献

1
Real-World Outcomes of Antiangiogenic Therapy in Patients With Wet Age-Related Macular Degeneration.湿性年龄相关性黄斑变性患者抗血管生成治疗的真实世界结果
Cureus. 2025 Aug 12;17(8):e89937. doi: 10.7759/cureus.89937. eCollection 2025 Aug.
2
Elevated Visual Crowding in CRB1-Associated Retinopathies: Understanding Functional Visual Deficits Using Child-Friendly Computerized Testing.CRB1相关视网膜病变中视觉拥挤现象加剧:利用儿童友好型计算机化测试理解功能性视觉缺陷
Invest Ophthalmol Vis Sci. 2025 May 1;66(5):32. doi: 10.1167/iovs.66.5.32.
3
Assessing Contrast Sensitivity Function in CRB1-Retinopathies: Exploring Child-Friendly Measures of Visual Function.
评估CRB1视网膜病变中的对比敏感度功能:探索视觉功能的儿童友好测量方法。
Transl Vis Sci Technol. 2024 Dec 2;13(12):33. doi: 10.1167/tvst.13.12.33.
4
Update on Clinical Trial Endpoints in Gene Therapy Trials for Inherited Retinal Diseases.遗传性视网膜疾病基因治疗试验的临床试验终点更新
J Clin Med. 2024 Sep 18;13(18):5512. doi: 10.3390/jcm13185512.
5
Expert CONsensus on Visual Evaluation in Retinal disease manaGEment: the CONVERGE study.视网膜疾病管理中视觉评估专家共识:CONVERGE研究
Br J Ophthalmol. 2025 Jan 28;109(2):228-236. doi: 10.1136/bjo-2024-325310.
6
Vision screening and refraction of Greenlandic schoolchildren.格陵兰学龄儿童的视力筛查与验光
Acta Ophthalmol. 2025 Mar;103(2):162-170. doi: 10.1111/aos.16740. Epub 2024 Jul 14.
7
Visual Function Measurements in Eyes With Diabetic Retinopathy: An Expert Opinion on Available Measures.糖尿病视网膜病变患者的视觉功能测量:关于现有测量方法的专家意见
Ophthalmol Sci. 2024 Apr 6;4(5):100519. doi: 10.1016/j.xops.2024.100519. eCollection 2024 Sep-Oct.
8
Visual Acuity Examination Methodology in Keratoconus.圆锥角膜的视力检查方法
J Clin Med. 2023 Dec 11;12(24):7620. doi: 10.3390/jcm12247620.
9
TREYESCAN: configuration of an eye tracking test for the measurement of compensatory eye movements in patients with visual field defects.特雷扫描:一种用于测量视野缺损患者代偿性眼球运动的眼动测试的配置。
Sci Rep. 2023 Nov 22;13(1):20479. doi: 10.1038/s41598-023-47470-5.
10
Magnitude of Visual Acuity Change with ETDRS versus Snellen Testing in Clinical Trials: Implications for Clinic-Based Outcomes.临床试验中采用ETDRS视力表与斯内伦视力表测试时视力变化的幅度:对基于临床的结果的影响
Ophthalmol Sci. 2023 Jul 19;4(2):100372. doi: 10.1016/j.xops.2023.100372. eCollection 2024 Mar-Apr.